# An Observational Study to Learn More About the Impact of Gadoxetate Sodium-Enhanced Magnetic Resonance Imaging (EOB-MRI) When Used to Diagnose the Spread of Cancer From the Pancreas to the Liver in Japanese People Under Real-World Conditions

> **NCT06106568** · — · COMPLETED · sponsor: **Bayer** · enrollment: 39624 (actual)

## Conditions studied

- Metastatic Pancreatic Cancer
- Liver Metastases
- Gadoxetate Sodium-enhanced Magnetic Resonance Imaging

## Interventions

- **PROCEDURE:** EOB-MRI
- **PROCEDURE:** Surgery
- **PROCEDURE:** Open-close Laparotomy

## Key facts

- **NCT ID:** NCT06106568
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-11-20
- **Primary completion:** 2024-10-30
- **Final completion:** 2024-10-30
- **Target enrollment:** 39624 (ACTUAL)
- **Last updated:** 2024-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06106568

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06106568, "An Observational Study to Learn More About the Impact of Gadoxetate Sodium-Enhanced Magnetic Resonance Imaging (EOB-MRI) When Used to Diagnose the Spread of Cancer From the Pancreas to the Liver in Japanese People Under Real-World Conditions". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06106568. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*